Quoin Pharmaceuticals, Ltd. American Depositary Shares Share Price
NASDAQ: QNRX | Micro CapQuoin Pharmaceuticals, Ltd. American Depositary Shares Stock Performance
Open $4.87 | Prev. Close $4.83 | Circuit Range N/A |
Day Range $4.87 - $4.93 | Year Range $3.46 - $39.00 | Volume 566 |
Average Traded $4.91 |
Quoin Pharmaceuticals, Ltd. American Depositary Shares Share Price Today
As of 11 August 2026, Quoin Pharmaceuticals, Ltd. American Depositary Shares's share price is $4.93. The stock opened at $4.87, compared to its previous close of $4.83. During today's trading session, Quoin Pharmaceuticals, Ltd. American Depositary Shares's share price traded between $4.87 and $4.93, with an average price of $4.90. Over the past 52 weeks, the stock has recorded a high of $39.00 and a low of $3.46. In terms of performance, Quoin Pharmaceuticals, Ltd. American Depositary Shares's share price has declined by 41.97% over the last six months and is down 35.22% on a year-on-year basis.
Quoin Pharmaceuticals, Ltd. American Depositary Shares Share Price Chart
Quoin Pharmaceuticals, Ltd. American Depositary Shares Stock Fundamentals & Key Indicators
Market Cap $5.27M | PE Ratio (TTM) -0.33 | Dividend Yield N/A |
EPS (TTM) $-14.80 | Revenue (TTM) N/A | Return On Equity (TTM) -120.46% |
Profit Margin N/A | Debt to Equity 0.42 | Quarterly Earnings Growth YoY -68.02% |
Quoin Pharmaceuticals, Ltd. American Depositary Shares Quarterly Profit & Loss
All figures in USD
Quoin Pharmaceuticals, Ltd. American Depositary Shares Annual Profit & Loss
All figures in USD
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Quoin Pharmaceuticals, Ltd. American Depositary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.48 | $4.93 | +12.81% |
Jul 2026 | $4.71 | $4.37 | -7.81% |
Jun 2026 | $4.63 | $4.74 | -5.95% |
May 2026 | $6.26 | $5.04 | -17.85% |
Apr 2026 | $5.95 | $6.13 | -5.47% |
Mar 2026 | $8.71 | $6.49 | -23.60% |
Feb 2026 | $7.40 | $8.49 | +16.37% |
Jan 2026 | $13.85 | $7.30 | -48.04% |
Dec 2025 | $18.82 | $14.05 | -32.68% |
Nov 2025 | $10.95 | $20.87 | +84.69% |
Oct 2025 | $8.14 | $11.30 | +60.74% |
Sep 2025 | $9.38 | $7.03 | -7.62% |
QNRX Share Price FAQs
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares share price today?
What is the 52 week high and 52 week low of Quoin Pharmaceuticals, Ltd. American Depositary Shares stock?
What is QNRX's market capitalisation today?
What is QNRX's net income for the last quarter?
What is the 5 year returns of QNRX?
What is the high & low stock price of QNRX today?
Can I buy QNRX shares in India?